BELOVAX Trademark

Trademark Overview

On Tuesday, September 18, 2012, a trademark application was filed for BELOVAX with the United States Patent and Trademark Office. The USPTO has given the BELOVAX trademark a serial number of 85731524. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2017. This trademark is owned by Glaxo Group Limited. The BELOVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
belovax

General Information

Serial Number85731524
Word MarkBELOVAX
Filing DateTuesday, September 18, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Tuesday, December 26, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 25, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2017EXTENSION 5 GRANTED
Thursday, April 27, 2017EXTENSION 5 FILED
Thursday, April 27, 2017TEAS EXTENSION RECEIVED
Saturday, October 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 21, 2016EXTENSION 4 GRANTED
Thursday, October 13, 2016EXTENSION 4 FILED
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Wednesday, April 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016EXTENSION 3 GRANTED
Thursday, April 14, 2016EXTENSION 3 FILED
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Friday, October 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2015EXTENSION 2 GRANTED
Monday, October 19, 2015EXTENSION 2 FILED
Monday, October 19, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 8, 2015EARLY EXTENSION OF USE REFUSED
Tuesday, May 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Tuesday, March 31, 2015EXTENSION 1 GRANTED
Tuesday, March 31, 2015EXTENSION 1 FILED
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, November 1, 2014APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT
Thursday, October 30, 2014ASSIGNED TO PETITION STAFF
Tuesday, October 21, 2014TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, February 7, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 26, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 24, 2013ASSIGNED TO LIE
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 22, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 22, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, January 22, 2013SUSPENSION LETTER WRITTEN
Tuesday, January 15, 2013ASSIGNED TO EXAMINER
Friday, September 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 21, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

belovax pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological